Seer (NASDAQ:SEER) Announces Quarterly Earnings Results

Seer (NASDAQ:SEER) posted its earnings results on Tuesday. The company reported ($0.25) EPS for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.01, FiscalAI reports. The firm had revenue of $3.98 million during the quarter, compared to analysts’ expectations of $4.15 million. Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%.

Seer Stock Down 4.2%

Seer stock traded down $0.07 during trading hours on Tuesday, hitting $1.61. The stock had a trading volume of 125,604 shares, compared to its average volume of 521,158. The stock has a market cap of $89.15 million, a price-to-earnings ratio of -1.32 and a beta of 1.49. Seer has a one year low of $1.55 and a one year high of $2.38. The business’s 50 day simple moving average is $1.97 and its 200-day simple moving average is $1.91.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a research note on Thursday, October 15th. Two analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $4.00.

About Seer

Seer, Inc. is a life sciences company that develops technologies for large-scale protein analysis, known as proteomics. The company’s platform is designed to help researchers study a broad range of proteins in biological samples and generate detailed information that may support drug discovery, disease research and biomarker development. Seer’s primary offering is the Proteograph Product Suite, which combines engineered nanoparticle technology, laboratory consumables, automation and software. The system is intended to provide deep, unbiased proteomic analysis from relatively small biological samples, including blood and other complex specimens.